Herbas VPB

Print
EN | LT
LT - Humanizuoti antikūnai prieš komplemento faktorių C1Q ir jų panaudojimas
EN - HUMANIZED ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/18 (2006.01)
A61K 39/395 (2006.01)
A61K 49/00 (2006.01)
A61K 49/16 (2006.01)
G01N 33/564 (2006.01)
G01N 33/68 (2006.01)
A61P 3/00 (2006.01)
A61P 3/04 (2006.01)
A61P 3/10 (2006.01)
A61P 7/06 (2006.01)
A61P 9/10 (2006.01)
A61P 21/04 (2006.01)
A61P 25/00 (2006.01)
A61P 25/14 (2006.01)
A61P 25/16 (2006.01)
A61P 25/28 (2006.01)
A61P 29/00 (2006.01)
A61P 35/00 (2006.01)
A61P 37/02 (2006.01)
A61P 37/06 (2006.01)
European patent
(11) Number of the document 3215527
(13) Kind of document T
(96) European patent application number 15857258.6
Date of filing the European patent application 2015-11-05
(97) Date of publication of the European application 2017-09-13
(45) Date of publication and mention of the grant of the patent 2025-01-08
(46) Date of publication of the claims translation 2025-04-10
PCT application
(86) Number PCT/US2015/059185
Date 2015-11-05
PCT application publication
(87) Number WO 2016/073685
Date 2016-05-12
Priority applications
(30) Number Date Country code
201462075793 P 2014-11-05 US
Inventors
(72)
ROSENTHAL, Arnon , US
LEVITEN, Michael , US
Grantee
(73) Annexon, Inc. , 1400 Sierra Point Parkway Building C, 2nd Floor, Brisbane, CA 94005, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Humanizuoti antikūnai prieš komplemento faktorių C1Q ir jų panaudojimas
  HUMANIZED ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF